rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Adrian Miranda

CMO, SVP Science & Tech

Company insider

Files Form 4 as: CMO, SVP Science & Tech, Neuraxis.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
3 Jan 2025
Last trade
24 Aug 2026
Last filed
26 Aug 2026

Companies traded

Where they are an officer
NRXS NeuraxisOfficer · Medical Devices · last 24 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
24 Aug 2026filed 26 Aug 2026NRXS NeuraxisMedical DevicesSEC FORM 4 Code A—199,106filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code C$2.3M337,204 at $6.94filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A—337,204filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code C$2.3M337,204 at $6.94filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A—337,204filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code C—337,204filing
24 Aug 2026filed 26 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code C—337,204filing
24 Aug 2026filed 26 Aug 2026NRXS NeuraxisMedical DevicesSEC FORM 4 Code A—199,106filing
13 Aug 2026filed 17 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$837K133,341 at $6.28filing
13 Aug 2026filed 17 Aug 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$837K133,341 at $6.28filing
22 Jan 2026filed 2 Mar 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$220K47,569 at $4.63filing
22 Jan 2026filed 2 Mar 2026NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$220K47,569 at $4.63filing
4 Mar 2025filed 10 Sep 2025NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$22K10,000 at $2.18filing
4 Mar 2025filed 10 Sep 2025NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$65K30,000 at $2.18filing
3 Jan 2025filed 10 Sep 2025NRXS Neuraxisoption or derivative · Medical DevicesSEC FORM 4 Code A$85K35,000 at $2.42filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Timothy Robert HenrichsChief Financial Officer · Chief Financial Officer at Neuraxis, filing Form 4 there in the last year
Brian Allen CarricoChief Executive Officer · Chief Executive Officer at Neuraxis, filing Form 4 there in the last year
Thomas Joeseph CarricoCro, Cco, Cpo · Cro, Cco, Cpo at Neuraxis, filing Form 4 there in the last year
Jane Elizabeth KeyserDirector · Director at Neuraxis, filing Form 4 there in the last year
Kristin A. FergeDirector · Director at Neuraxis, filing Form 4 there in the last year